SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-027927
Filing Date
2024-03-07
Accepted
2024-03-07 16:05:46
Documents
92
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nmra-20231231.htm   iXBRL 10-K 3006896
2 EX-10.22 nmra-ex10_22.htm EX-10.22 121363
3 EX-10.23 nmra-ex10_23.htm EX-10.23 120666
4 EX-23.1 nmra-ex23_1.htm EX-23.1 4142
5 EX-31.1 nmra-ex31_1.htm EX-31.1 16377
6 EX-31.2 nmra-ex31_2.htm EX-31.2 16370
7 EX-32.1 nmra-ex32_1.htm EX-32.1 9679
8 EX-32.2 nmra-ex32_2.htm EX-32.2 9639
9 EX-97.1 nmra-ex97_1.htm EX-97.1 36938
10 GRAPHIC img234951805_0.jpg GRAPHIC 201399
11 GRAPHIC img234951805_1.jpg GRAPHIC 22513
12 GRAPHIC img234951805_2.jpg GRAPHIC 63611
13 GRAPHIC img234951805_3.jpg GRAPHIC 22856
14 GRAPHIC img234951805_4.jpg GRAPHIC 31557
15 GRAPHIC img234951805_5.jpg GRAPHIC 201399
  Complete submission text file 0000950170-24-027927.txt   12821279

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nmra-20231231.xsd EX-101.SCH 1493919
94 EXTRACTED XBRL INSTANCE DOCUMENT nmra-20231231_htm.xml XML 1880667
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41802 | Film No.: 24730051
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)